69 related articles for article (PubMed ID: 8907210)
1. Inhibition of isoprenoid biosynthesis and arterial smooth-muscle cell proliferation.
Soma MR; Parolini C; Donetti E; Fumagalli R; Paoletti R
J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S20-4. PubMed ID: 8907210
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
Soma MR; Donetti E; Parolini C; Mazzini G; Ferrari C; Fumagalli R; Paoletti R
Arterioscler Thromb; 1993 Apr; 13(4):571-8. PubMed ID: 8466892
[TBL] [Abstract][Full Text] [Related]
3. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R
Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of statins on the vascular wall.
Corsini A; Pazzucconi F; Arnaboldi L; Pfister P; Fumagalli R; Paoletti R; Sirtori CR
J Cardiovasc Pharmacol; 1998 May; 31(5):773-8. PubMed ID: 9593078
[TBL] [Abstract][Full Text] [Related]
8. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
11. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
Hughes AD
J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
[TBL] [Abstract][Full Text] [Related]
12. Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells.
Baetta R; Donetti E; Comparato C; Calore M; Rossi A; Teruzzi C; Paoletti R; Fumagalli R; Soma MR
Pharmacol Res; 1997 Aug; 36(2):115-21. PubMed ID: 9344639
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro.
Rogler G; Lackner KJ; Schmitz G
Am J Cardiol; 1995 Jul; 76(2):114A-116A. PubMed ID: 7604784
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacology of the statins: the evidence of a direct antiatherosclerotic action].
Raiteri M; Arnaboldi L; Quarato P; Paoletti R; Fumagalli R; Corsini A
Ann Ital Med Int; 1995 Oct; 10 Suppl():35S-42S. PubMed ID: 8562263
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression.
Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A
Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661
[TBL] [Abstract][Full Text] [Related]
17. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.
Corpataux JM; Naik J; Porter KE; London NJ
J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194
[TBL] [Abstract][Full Text] [Related]
18. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
19. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N
J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
Chen H; Xing Y; Liu R
Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
